New York Cannabis: Social and Economic Equity Applicants

As we previously broadly summarized on December 27, 2022 (here), in late December 2022, the Office of Cannabis Management (“OCM”) released its first proposed adult-use cannabis rules and regulation for New York (the “Proposed Regulations”). The official document is 282 pages, so we won’t cover every detail. But we will highlight the big-ticket items, significant issues that all applicants should be aware of, and the license application process as a whole.  This post will go into detail the Social and Economic Equity sections and commentary provided for in the Proposed Regulations.  Keep in mind, the Proposed Regulations are still pending as OCM receives the final public comments to the Proposed Regulations.

For anyone considering applying for an adult-use license, we reiterate our recommendation of hiring an experienced, local cannabis attorney. At a minimum, understanding the overall framework of the licenses and the licensing process is a precursor to an in-depth consultation on a license application.

One of the more notable topics covered in depth by the Proposed Regulations is the establishment of a social and economic equity applicant, and licensee. If you remember, the Marijuana Regulation and Tax Act (“MRTA”) established a goal to award 50% of all adult-use cannabis licenses to

Read More Here...

Argentina Sets High Hopes On Cannabis Exports With Budding New Agency

Argentina on Wednesday launched the first working group of a new national agency to regularize and promote the country’s nascent cannabis industry, which ministers hope will create new jobs and exports generating fresh income for the South American nation. “This opens the door for Argentina to start a new path in terms of industrial exports, on the basis of huge global demand,” said Economy Minister Sergio Massa in a conference launching the national hemp and…

Read More Here...

Cannabis Acceptance as Legitimate Pain Relief Medication

A new survey shows how frequently cannabis is used to treat chronic pain. Fifty million American adults (20 percent) suffer from chronic pain, with almost 20 million having high-impact chronic pain, defined as substantially restricting activities for six months or more. A new study, reviewed by Johns Hopkins School of Public Health, now shows how well-accepted cannabis has become as a treatment for chronic pain in states permitting its medicinal use.[1] Research on medical cannabis…

Read More Here...

Is Cannabis The Secret To Orgasms For Women? Females Who Smoke Before Sex Are More Likely To Climax Multiple Times, Study Suggests

Cannabis use could be the key to multiple orgasms among women – as less than 50 percent report climaxing during a sexual encounter. A new survey of hundreds of people showed that women who smoke before sex or masturbate have improved orgasm capacity per encounter. The study, conducted by North Carolina researchers, suggested this is likely due to the drug making women relaxed and increasing their desire, which means the recreational drug could treat sexual…

Read More Here...

Breaking: FDA Says “No” to CBD Foods and Dietary Supplements

Since the passage of the 2018 Farm Bill, the hemp CBD industry has been eagerly awaiting FDA CBD regulations. In that time, FDA convened a working group to study how the agency would regulate CBD foods and dietary supplements. As of January 26, 2023, the FDA concluded that it will NOT regulate CBD foods or dietary supplements.

FDA and the States on CBD since the Farm Bill

Before jumping into the post, it bears noting that the FDA has taken the position, literally since the day the 2018 Farm Bill was passed, that CBD foods and dietary supplements violate the Food, Drug & Cosmetic Act. Nevertheless, it has issued only periodic warning letters and taken minimal actions against the CBD industry beyond these letters. The agency has also tended to focus more on egregious misconduct.

In the face of the FDA’s limited responses, states have filled the void with their own regulations, though we always knew the FDA was considering CBD food and dietary supplement regulations.

Now, the FDA is declining to move forward with regulations but has indicated that it would work with Congress if it passes separate CBD legislation. This is because the FDA concluded that its existing

Read More Here...